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Research
The burden of liver disease has increased in 
the United States in parallel with the obesity 
epidemic, and some cases are believed to 
be due to nonalcoholic fatty liver disease 
(NAFLD) or its more advanced form, non-
alcoholic steatohepatitis (NASH) (Cave 
et al. 2007). Serum alanine aminotransferase 
(ALT) is the most specific of the routinely 
used biomarkers for hepatocellular liver injury 
and disease in clinical medicine (Green and 
Flamm 2002). Currently, there is no sero-
logic biomarker to confirm the diagnosis of 
NAFLD, but ALT elevation (above normal 
laboratory reference ranges) is the most com-
mon laboratory manifestation of NAFLD, 
and ALT elevation unexplained by viral hepa-
titis, ethanol, or iron overload has been used 
as a surrogate biomarker for NAFLD in the 
National Health and Nutrition Examination 
Survey (NHANES) (Clark 2006). Using 
this approach, Clark et al. (2003) reported 
that “unexplained ALT elevation” or “sus-
pected NAFLD” was present in 5.4% of 
adult NHANES III (1988–1994) partici-
pants. Since the publication of that study, 
unexplained ALT elevation has been rapidly 
adopted by other authors to define subpop-
ulations within NHANES with suspected 
NAFLD (Clark et al. 2003; Dunn et al. 2008; 
Liangpunsakul and Chalasani 2004, 2005).
High-level occupational exposures to 
industrial chemicals have been associated with 
liver diseases, including NAFLD (Cave et al. 
2007; Cotrim et al. 1999, 2004). Recently, 
insulin resistance and toxicant-associated 
steato  hepatitis (TASH), a form of NASH, 
were reported in nonobese chemical workers   
who had been highly exposed to vinyl chlo-
ride (Cave et al. 2010). However, the poten-
tial influence of low-level environ  mental 
pollution on liver disease and suspected 
NAFLD in the general population has not 
been determined. Recently, pollutant levels 
were measured in NHANES participants, 
and specific pollutants were found to be asso-
ciated with insulin resistance and metabolic 
syndrome (Lee et al. 2007a, 2007b), although 
liver disease was not evaluated. 
In the present study, we tested the 
hypothesis that environmental pollutants are 
dose-dependently associated with increased 
risk for ALT elevation and suspected NAFLD 
in the NHANES adult population.
Materials and Methods
Study design and participants. Adult par-
ticipants from NHANES 2003–2004, the 
most recent NHANES for which pollutant 
data were posted at the time of analysis, were 
evaluated in this cross-sectional cohort study. 
NHANES is conducted by the National 
Center for Health Statistics (NCHS) to eval-
uate the health and nutrition of Americans, 
and it is designed to be nationally representa-
tive of the noninstitutionalized U.S. civilian 
population on the basis of a complex mul-
tistage probability sample (NCHS 2005). 
Approval for our analysis of the NHANES 
data was granted by the University of 
Louisville Institutional Review Board. 
For our study, we used the following 
exclusion criteria: age < 18 years, positive 
serum hepatitis B surface antigen, positive 
serum hepatitis C antibody, elevated trans-
ferrin saturation (> 60% for men and 
> 50% for women), and alcohol consump-
tion ≥ 20 g/day for men and ≥ 10 g/day for 
women. Consistent with prior studies, these 
exclusions were used to identify suspected 
cases of NAFLD based on ALT elevation in 
the absence of other identifiable causes of 
liver disease (Clark et al. 2003). A total of 
10,122 subjects were evaluated for eligibility, 
but after applying these exclusion criteria and 
eliminating another 643 subjects with miss-
ing ALT values, the final maximum sample 
size was 4,582 (Figure 1).
Pollutants. All pollutant data posted by the 
NCHS before December 2008 were accessed 
and downloaded, which yielded 196 pollut-
ants from 17 subclasses as categorized by the 
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Ba c k g r o u n d: High-level occupational exposures to some industrial chemicals have been associated 
with liver diseases, including nonalcoholic fatty liver disease (NAFLD). However, the potential role of 
low-level environmental pollution on liver disease in the general population has not been evaluated.
oB j e c t i v e: We determined whether environmental pollutants are associated with an elevation in 
serum alanine aminotransferase (ALT) activity and suspected NAFLD in U.S. adults.
Me t h o d s : This cross-sectional cohort study evaluated adult participants without viral hepatitis, 
hemochromatosis, or alcoholic liver disease from the National Health and Nutrition Examination 
Survey (NHANES) for 2003–2004. ALT elevation was defined in men as ≥ 37 IU/L (age18–20 
years) and ≥ 48 IU/L (age ≥ 21 years) and in women as ≥ 30 IU/L (age 18–20 years) and ≥ 31 IU/L 
(age ≥ 21 years). Adjusted odds ratios (ORs) for ALT elevation were determined across exposure 
quartiles for 17 pollutant subclasses comprising 111 individual pollutants present with at least a 
60% detection rate. Adjustments were made for age, race/ethnicity, sex, body mass index, poverty 
income ratio, and insulin resistance. Individual pollutants from subclasses associated with ALT 
elevation were subsequently analyzed.
re s u l t s: The overall prevalence of ALT elevation was 10.6%. Heavy metals and polychlorinated 
biphenyls (PCBs) were associated with dose-dependent increased adjusted ORs for ALT elevation. 
Within these subclasses, increasing whole-blood levels of lead and mercury and increasing lipid-
adjusted serum levels of 20 PCBs were individually associated with ALT elevation.
co n c l u s i o n s: PCB, lead, and mercury exposures were associated with unexplained ALT elevation, 
a proxy marker of NAFLD, in NHANES 2003–2004 adult participants.
key w o r d s : environmental liver disease, hepatotoxicity, lead, mercury, NAFLD, NASH, nonalcoholic 
fatty liver disease, nonalcoholic steatohepatitis, PCBs, polychlorinated biphenyls, TASH. Environ 
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NCHS: serum perfluorinated compounds; uri-
nary heavy metals; urinary total arsenic and 
speciated arsenics; urinary total (elemental plus 
inorganic) mercury; serum organochlorine pes-
ticides; serum polybrominated diphenyl ethers 
(PBDEs); urinary polyaromatic hydrocarbons; 
urinary phthalates; serum polychlorinated 
dibenzo-p-dioxins (PCDDs), polychlorinated 
dibenzofurans (PCDFs), and coplanar poly-
chlorinated biphenyls (PCBs); serum non–
dioxin-like PCBs; urinary organophosphate 
insecticides; urinary perchlorate; urinary envi-
ronmental phenols; urinary iodine; blood lead, 
mercury (total and inorganic), and cadmium; 
serum cotinine; and blood volatile organic com-
pounds [for the full list of chemicals in each 
subclass, see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002720)]. An additional 
subclass, coplanar PCBs, was constructed by 
selecting only these chemicals from the broader 
“PCDDs, PCDFs, and coplanar PCBs” sub-
class. A second subclass for total PCBs was 
then created by combining the non–dioxin-like 
PCBs and coplanar PCBs subclasses.
All ALT and pollutant levels were meas-
ured in biologic samples collected on the same 
day from each individual participant. We eval-
uated only pollutants with a ≥ 60% detection 
rate [111 of 196 pollutants; see Supplemental 
Material, Table 1 (doi:10.1289/ehp.1002720)] 
to avoid bias in estimation for those pollut-
ants with levels < the lower limit of detection 
(Lee et al. 2007a, 2007b). Concentrations of 
organic pollutants measured in serum (non–
dioxin-like PCBs; dioxins, furans, coplanar 
PCBs; PBDEs; organochlorine pesticides) were 
lipid adjusted, and concentrations of pollutants 
measured in urine were adjusted for creatinine 
[Supplemental Material, Table 1 (doi:10.1289/
ehp.1002720)] (Schwartz et al. 2003).
Outcome  variables  and  statistical   
methods. Serum ALT activity was measured 
by Collaborative Laboratory Services, LLC 
(Ottumwa, IA) for NHANES using the 
Beckman Synchron LX20 (Beckman Coulter, 
Brea, CA). Elevated ALT was defined as any 
value greater than this laboratory’s refer-
ence range, which was established from data 
obtained from healthy wellness participants 
as described in the NHANES Laboratory 
Procedure Manual (NCHS 2003–2004). 
Specifically, we used nonparametric techniques 
to estimate lower and upper bounds of   
reference ranges (2.5th and 97.5th percentiles) 
according to age and sex (Reed et al. 1971). 
ALT above the reference range was classified 
as elevated (men 18–20 years of age, ALT ≥ 37 
IU/L; men ≥ 21 years old, ALT ≥ 48 IU/L; 
women 18–20 years of age, ALT ≥ 30 IU/L; 
women ≥ 21 years of age, ALT ≥ 31 IU/L). We 
determined the prevalence of ALT elevation in 
4,582 subjects, and we used the chi-square test 
to determine statistically significant differences 
(p < 0.05) in ALT elevation and pollutant 
exposures according to sex, age, race/ethnicity, 
and body mass index (BMI).
Pollutant concentrations were classi-
fied according to a common scale that could 
be aggregated to assess cumulative exposures 
to multiple pollutants within a subclass. 
Specifically, we ranked each participant accord-
ing to their measured concentration of each 
pollutant and summed the ranks of each one 
within a given subclass to determine their com-
bined exposure (Lee et al. 2007a, 2007b). Ties 
were handled by assigning the minimum of 
the corresponding ranks to each participant, 
and participants with levels < the lower limit of 
detection (LLOD) for a pollutant were assigned 
the LLOD and ranked accordingly. For each 
pollutant subclass, subjects were stratified into 
quartiles by their cumulative exposure rank, 
with the first quartile representing subjects with 
the lowest levels. We estimated multivariate-
  adjusted odds ratios (ORs) for unexplained 
ALT elevation using logistic regression models 
with the first quartile as the reference group. 
Models were adjusted for age, race/ethnic-
ity, and poverty income ratio (PIR). We also 
adjusted for both BMI and homeostasis model 
assessment of insulin resistance (HOMA-IR), 
because multiple pollutants have previously 
been associated with obesity and insulin resis-
tance in NHANES (Lee et al. 2007a, 2007b). 
However, fasting glucose and insulin were 
measured in only a subset of NHANES partic-
ipants, so only 2,211 subjects could be evalu-
ated in this fashion. Further, although lead, 
cadmium, and mercury measurements were 
available for all 2,211 of these observations, 
other pollutant subclasses were measured only 
in subsets of this sample (perfluorinated chemi-
cals, 785 subjects; organochlorine pesticides 
and polybrominated diethyl ethers, 724 sub-
jects; dioxins, furans, coplanar PCBs, and non–
dioxin-like PCBs, 702 subjects; see Figure 1).
Associations with individual chemicals 
were estimated if trend tests for the associa-
tion between the entire subclass and elevated 
ALT were statistically significant. Subjects 
with detectable levels of individual pollut-
ants were ranked, placed into quartiles, and 
compared with a reference group consisting of 
individuals with levels < LLOD or individu-
als in the first quartile of exposure (if none of 
the subjects had levels < LLOD, or if none of 
Figure 1. Schematic diagram depicting adult NHANES 2003–2004 subjects and pollutant subclasses ana-
lyzed. nhoma refers to the subset of subjects with HOMA-IR scores, which were required for data adjust-
ment, and represents the maximum number of subjects available for each subpopulation for analysis by 
the primary model that adjusted for insulin resistance. The actual numbers used varied by analyte primar-
ily because of missing response variables required for the other adjustments. The final numbers used 
for each analyte or chemical subclass are given in Tables 2–5 and in the Supplemental Material, Tables 
2–5 (doi:10.1289/ehp.1002720). Volatile organic compounds were measured in selected subjects from 
  subpopulations B and D.
NHANES 2003–2004
n = 10,122
Subpopulation D
n = 1,466
nhoma = 702
Serum: dioxins, furans and 
coplanar PCBs, non−dioxin-
like PCBs
Blood: volatile organic compunds
Urine: organophosphates, 
perchlorate, environmental 
phenols, iodine
Subpopulation B
n = 1,599
nhoma = 785
Serum: perﬂuorinated chemicals
Blood: volatile organic 
compunds
Urine: heavy metals, total and 
speciated arsenics, total 
mercury
Subpopulation C
n = 1,517
nhoma = 724
Serum: organochlorine 
pesticides, polybrominated 
diphenyl ethers
Urine: polyaromatic hydro-
carbons, phthalates
Subpopulation A
n = 4,582
nhoma = 2,211
Serum: cotinine
Blood: lead, cadmium, and mercury
After primary exclusions
(1) Age < 18 years
(2) Other liver diseases 
(i.e., hepatitis B or 
hepatitis C), alcohol 
abuse, or iron overload 
(3) Missing ALTEnvironmental pollution and liver disease in adults
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the subjects with levels < LLOD had elevated 
ALT). In the latter situation, subjects with 
levels < LLOD were still used in calculating 
the trend statistic for association of exposure 
level with elevated ALT.
We performed all statistical analyses using 
SURVEYFREQ and SURVEYLOGISTIC 
in SAS (version 9.1; SAS Institute Inc., Cary, 
NC). Estimates were adjusted for age, race/
ethnicity, and PIR rather than using sample 
weights, which is regarded as a good compro-
mise between efficiency and bias (Graubard 
and Korn 1999; Korn and Graubard 1991). 
Trend tests for the association between pol-
lutants (both individual and cumulative for a 
subclass) were performed by modeling ordi-
nal variables with integer scores assigned to 
each quartile and to the group of individuals 
with levels < LLOD, when appropriate [see 
Supplemental Material, Statistical Methods 
(doi:10.1289/ehp.1002720)]. p-Values 
were determined, both with (adjusted ptrend) 
and without (ptrend), for multiple compari-
sons using the false discovery rate method of 
Benjamini and Hochberg (1995), and both 
p-values are reported because adjustment for 
multiple comparisons has not consistently 
been performed in the other studies (Lee et al. 
2007a, 2007b). Adjustments for multiple 
comparisons were done separately for subclass 
analyses and for analyses of individual pol-
lutants within subclasses. We used a p-value 
≤ 0.05 to indicate statistical significance.
Results
Demographic information. The full study sam-
ple included slightly more women than men 
(Table 1). The mean age (and corresponding 
SD) was 47.2 ± 21.2 years (range, 18–85 years). 
Non-Hispanic whites accounted for 72.3% of 
the population. Body weights, as defined by 
National Institutes of Health (1998) guidelines, 
were fairly evenly distributed between normal 
weight, overweight, and obese, with very few 
subjects being underweight (1.7%).
Prevalence of unexplained ALT elevation 
and PCB exposure. Of the 4,582 adult sub-
jects remaining after applying the exclusion 
criteria, 436 had unexplained ALT elevation 
(i.e., suspected NAFLD), which corresponds 
to 10.6% of the U.S. adult population or 19.4 
million people (after accounting for NHANES 
sampling weights). ALT elevation was more 
common in women than in men (11.9% vs. 
9.2%; p = 0.020) (Table 1). ALT elevation 
was more common in Hispanics than in non-
Hispanic whites (18.6% vs. 10.0%), whereas 
non-Hispanic blacks had a lower prevalence of 
ALT elevation (5.6%; p = 0.001). ALT eleva-
tion was most prevalent during the fifth and 
sixth decades and was more prevalent in over-
weight and obese participants than in normal-
weight participants (10.7%, 15.7%, and 5.1%, 
respectively; p = 0.001).
Older age and non-Hispanic black race, 
but not BMI or sex, were significantly asso-
ciated with total PCB levels in the highest 
quartile (Table 1). Age had the most pro-
nounced association: 71.7% of participants 
age ≥ 70 years had PCB levels in the high-
est quartile, compared with only 2.2% of 
subjects < 30 years of age (p < 0.001). Non-
Hispanic blacks (29.2%) were more likely to 
be in the highest quartile of total cumulative 
PCB exposure than were non-Hispanic whites 
(21.7%) and Hispanics (8.2%; p = 0.002).
Pollutant subclass results. We estimated 
significant positive trends for adjusted ORs 
for 3 of the 17 NHANES pollutant sub-
classes investigated (Table 2). Specifically, the 
adjusted ORs and 95% confidence intervals 
(CIs) for the highest versus lowest quartiles 
of exposure were for serum dioxins, furans, 
and coplanar PCBs, 5.8 (95% CI, 1.1–30.2; 
ptrend = 0.024); for serum non–dioxin-like 
PCBs, 4.5 (95% CI, 2.0–10.0; ptrend < 0.001); 
and for blood lead, mercury, and cadmium, 
1.6 (95% CI, 1.1–2.3; ptrend = 0.015). After 
adjusting for multiple comparisons, the trend 
test for non–dioxin-like PCBs remained 
statistically significant (ptrend-adj = 0.001). 
In general, results were comparable when 
estimated without adjustment for BMI or 
HOMA-IR [see Supplemental Material, 
Tables 3 and 4, respectively (doi:10.1289/
ehp.1002720)], although trend tests for 
associations with creatinine-adjusted urine 
polyaromatic hydrocarbons and serum lipid-
adjusted PBDEs indicated significant posi-
tive and negative trends in associations with 
ALT based on models without adjustment 
for HOMA-IR.
Significant positive trends were also evi-
dent for associations with coplanar PCBs and 
total PCBs (Table 2). The highest quartile of 
cumulative coplanar PCB exposure, compared 
with the lowest quartile, was associated with a 
significantly increased adjusted OR for ALT 
elevation of 7.6 (95% CI, 2.8–20.7; ptrend-
adj < 0.001). Likewise, the adjusted OR for 
the highest versus lowest quartile of exposure 
to cumulative total PCB subclass (coplanar 
PCBs plus non–dioxin like PCBs) was 4.3 
(95% CI, 1.8–10.1; ptrend-adj = 0.01).
Individual pollutant results. We also esti-
mated associations with 45 individual pol-
lutants from subclasses with significant trend 
tests. Blood lead (99.6%) and total mercury 
(92.5%) had extremely high detection rates 
and were positively associated with ALT ele-
vation, but cadmium exposure was not associ-
ated with ALT elevation (Table 3).
Ten coplanar PCBs were present at 
detection rates ranging from 68% to 100%, 
and nine of these were positively associated 
with elevated ALT (Table 4). However, 
none of the four PCDDs or three PCDFs 
was associated with ALT elevation [see 
Supplemental Material, Table 5 (doi:10.1289/
ehp.1002720)]. Twenty-five non–dioxin-like 
PCBs were present, with detection rates rang-
ing from 65.5% to 100%, and 11 of these 
were positively associated with ALT elevation 
with significant trends (Table 5).
Discussion
The prevalence of ALT elevation unexplained 
by viral hepatitis, hemochromatosis, or alco-
holism (i.e., suspected NAFLD) was 10.6% 
in NHANES 2003–2004, which was nearly 
Table 1. Prevalence of unexplained ALT elevation (suspected NAFLD) and association with elevated total 
PCB levels in adult NHANES 2003–2004, by demographic groups.
Demographic variable
Population  
distribution (%)
Prevalence of unexplained  
ALT elevation PCBs > 75th percentilea
Percent SE p-Value Percent SE p-Value
Sex 0.020 0.182
Male 47.8 9.2 0.8 18.5 2.1
Female 52.2 11.9 0.5 22.8 1.8
Race/ethnicity < 0.001 0.002
Non-Hispanic White 72.3 10.0 0.5 21.7 1.4
Non-Hispanic Black 10.8 5.6 0.8 29.2 2.9
Hispanic 11.7 18.6 1.5 8.2 2.2
Other 5.1 10.9 2.9 19.3 8.3
Age (years) 0.005 < 0.001
< 30 21.5 9.1 1.2 2.2 1.2
30–40 19.5 11.8 1.3 4.2 1.5
40–50 20.4 13.2 1.4 12.0 2.1
50–60 16.0 13.0 1.2 24.6 5.1
60–70 10.5 10.6 2.0 45.0 5.2
 ≥ 70 12.1 3.7 0.9 71.7 4.4
BMI (kg/m2) < 0.001 0.525
< 18.5 1.7 7.1 3.1 17.7 9.9
18.5–24.9 31.5 5.1 0.8 17.6 1.9
25–29.9 34.3 10.7 1.3 23.1 2.7
≥ 30 32.5 15.7 1.0 21.6 2.4
SE, standard error of the mean. p-Values were calculated by chi-square tests. aPercentage of subjects within a demo-
graphic group having lipid-adjusted serum total PCB levels in the highest exposure quartile.Cave et al.
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double the prevalence (5.4%) reported by a 
study of NHANES 1988–1994 adult partici-
pants that used similar exclusion criteria and 
a similar ALT reference range (Clark et al. 
2003). As in our study, Clark et al. (2003) 
also noted that ALT elevation was associated 
with BMI, Hispanic ethnicity, and middle 
age. The observed increase in the prevalence 
of ALT elevation from NHANES 1988–1994 
to NHANES 2003–2004 is consistent with 
the growing burden of obesity and NAFLD.
Because liver biopsy was not performed 
in NHANES, we used unexplained ALT ele-
vation as a proxy measure of liver disease and 
NAFLD and identified several ubiquitous 
environmental pollutants that were dose-de-
pendently associated with suspected NAFLD, 
including lead, mercury, and PCBs. Although 
levels of many pollutants are decreasing in 
the environment, PCB, lead, and mercury 
exposures remain problematic. For example, 
even though PCBs were banned in 1977, 
100% of subjects in this study had detectable 
PCB levels.
Diet-induced obesity probably plays the 
primary role in the pathogenesis of most cases 
of NAFLD (Cave et al. 2007), but nutrient–
toxicant interactions and genetic susceptibility 
to environmental pollution may be impor-
tant cofactors, which we did not address in 
this study. Data from our group and others 
suggest that diet-induced obesity and fatty 
liver decrease antioxidant defenses and impair 
xenobiotic metabolism and disposition, 
which could sensitize the liver to chemical 
injury (Fisher et al. 2009a, 2009b; Kirpich 
et al. in press). Further complicating this issue, 
lead, mercury, and coplanar PCBs concen-
trate within the liver, whereas non–dioxin-
like PCBs concentrate in adipose tissue and 
possibly in steatotic (fatty) livers [Klein et al. 
1972; Mudipalli 2007; National Toxicology 
Program (NTP) 2006a]. Therefore, tissue 
levels may not always correlate with serum 
levels. However, it is important to recognize 
that multiple animal studies demonstrate that 
PCBs and methylmercury (MeHg) expo-
sures induce fatty liver, even in the absence of 
diet-induced obesity (Chang and Yamaguchi 
1974; Desnoyers and Chang 1975b; Lin et al. 
1996; NTP 2006a, 2006b, 2006c). Although 
lead has been associated with hepatic hyper-
plasia and not NAFLD, to our knowledge lead 
and diet-induced obesity coexposures have not 
been performed in animal models (Mudipalli 
2007). The results of these aforementioned 
studies lend biologic plausibility to the hypoth-
esis that lead, mercury, and PCBs may play a 
previously unsuspected role in the pathogen-
esis of some cases of suspected NAFLD.
PCBs are polyhalogenated aromatic hydro-
carbons that consist of up to 10 chlorine atoms 
attached to a biphenyl group. About 130 of the 
209 theoretical PCB congeners were manufac-
tured between 1929 and 1977 as mixtures and 
were sold as a function of chlorine content. 
For example, Monsanto marketed Aroclors 
1221, 1231, and 1242 up to 1268, which 
contain, respectively, 21%, 31%, and 42% to 
68% chlorine by weight. Aroclors were used 
in multiple industrial applications and were 
components in dielectric insulating fluids for 
Table 2. Adjusted ORsa (95% CIs) for ALT elevation by exposure quartile for pollutant subclasses in adults, NHANES 2003–2004.
Pollutant subclass n
Pollutants 
screened/analyzedb
Quartile [cases/total, OR (95% CI)] p-Value
First Second Third Fourth Trend Adjusted trendc
Coplanar PCBs (serum) 535 10/9 12/133 
Referent
12/137 
2.2 (0.9–5.2)
18/141 
4.4 (1.8–10.5)
15/129 
7.6 (2.8–20.7)
< 0.001 < 0.001
Non–dioxin-like PCBs (serum) 532 26/25 18/125 
Referent
9/145 
0.8 (0.3–2.0)
15/131 
2.4 (1.1–5.2)
17/131 
4.5 (2.0–10.0)
< 0.001 0.001
Total PCBs (serum) 535 36/34 18/119 
Referent
8/129 
0.8 (0.3–2.3)
15/138 
2.2 (0.9–5.3)
15/119 
4.3 (1.8–10.1)
0.002 0.010
Dioxins, furans, coplanar PCBs (serum) 535 29/17 13/138 
Referent
12/136 
1.7 (0.7–4.4)
17/135 
3.6 (1.2–10.8)
13/126 
5.8 (1.1–30.2)
0.024 0.137
Lead, cadmium, mercury (blood) 2,051 4/3 57/520 
Referent
45/505 
0.9 (0.6–1.4)
49/518 
1.1 (0.8–1.7)
54/508 
1.6 (1.1–2.3)
0.015 0.126
Environmental phenols (urine) 643 4/3 19/145 
Referent
22/162 
1.2 (0.5–2.7)
11/165 
0.5 (0.2–1.3)
17/171 
0.9 (0.4–2.1)
0.333 0.811
Polyaromatic hydrocarbons (urine) 563 21/10 14/147 
Referent
10/139 
0.8 (0.3–2.6)
15/142 
1.0 (0.4–2.7)
17/135 
1.6 (0.6–4.6)
0.335 0.811
PBDEs (serum) 614 11/6 20/169 
Referent
19/149 
1.0 (0.5–1.9)
18/149 
0.9 (0.4–1.9)
13/147 
0.7 (0.3–1.5)
0.354 0.811
Volatile organic compounds (blood) 433 33/6 10/108 
Referent
16/97 
2.0 (0.8–4.7)
13/111 
1.3 (0.6–2.9)
14/117 
1.6 (0.8–3.4)
0.427 0.811
Perfluorinated compounds (serum) 694 12/4 18/189 
Referent
13/169 
0.8 (0.3–2.1)
12/167 
1.0 (0.3–3.0)
15/169 
1.6 (0.5–5.1)
0.460 0.811
Perchlorate (urine) 638 1/1 13/161 
Referent
17/163 
1.2 (0.6–2.3)
21/166 
1.4 (0.7–2.8)
18/148 
1.2 (0.5–2.9)
0.533 0.811
Phthalates (urine) 655 13/9 23/177 
Referent
17/158 
0.9 (0.3–2.3)
13/150 
0.6 (0.3–1.6)
19/170 
0.9 (0.5–1.6)
0.553 0.811
Organophosphate insecticides (urine) 631 6/4 26/159 
Referent
10/150 
0.4 (0.2–0.7)
13/157 
0.5 (0.2–1.0)
18/144 
0.8 (0.5–1.3)
0.561 0.811
Iodine (urine) 645 1/1 18/158 
Referent
16/160 
0.7 (0.4–1.2)
18/180 
0.7 (0.4–1.2)
16/147 
0.8 (0.4–1.5)
0.572 0.811
Total and speciated arsenics (urine) 710 8/3 15/188 
Referent
14/187 
0.8 (0.3–2.0)
17/170 
1.3 (0.7–2.3)
13/165 
0.9 (0.5–1.9)
0.725 0.901
Cotinine (serum) 2,050 1/1 54/527 
Referent
49/515 0.9 
(0.6–1.4)
58/504 
1.3 (0.9–1.9)
43/504 
1.0 (0.6–1.7)
0.783 0.901
Heavy metals (urine) 709 12/9 15/184 
Referent
17/197 
0.9 (0.4–1.9)
11/179 
0.5 (0.2–1.2)
16/149 
1.1 (0.5–2.3)
0.807 0.901
Organochlorine pesticides (serum) 587 13/8 15/136 
Referent
15/140 
0.9 (0.5–1.6)
21/155 
1.5 (0.5–4.2)
12/156 
0.9 (0.2–3.7)
0.848 0.901
Total mercury (urine) 707 1/1 11/180 
Referent
20/167 
2.3 (0.8–6.8)
11/169 
0.9 (0.3–2.8)
16/191 
1.5 (0.5–4.7)
0.918 0.918
Detectable values of each pollutant were individually ranked, and the rank orders of the individual pollutants in each subclass were summed to arrive at the subclass value. All 
  nondetectable values were ranked as one. The summary values were categorized by cutoff points of 25th, 50th, and 75th values of the sum of ranks. 
aORs were adjusted for age, sex, race, PIR, HOMA-IR, and BMI. bIn any given pollutant subclass, only chemicals with at least a 60% detection rate were included in the analysis. 
  cAdditionally adjusted for multiple comparisons.Environmental pollution and liver disease in adults
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transformers and capacitors, hydraulic fluids, 
plastics, and paints. An estimated 1.3 mil-
lion tons of PCBs were manufactured almost 
exclusively (97%) in the northern hemisphere 
(Breivik et al. 2002). Although PCBs have been 
banned in the United States for > 30 years, 
their high thermodynamic stability makes them 
resistant to biodegradation and thus persistent 
organic pollutants. More highly chlorinated 
PCBs tend to be metabolized and eliminated 
more slowly, and the PCBs identified in bio-
logic samples in this study were indeed the 
more highly chlorinated varieties.
From a mechanistic standpoint, a PCB’s 
structure determines its ability to interact with 
nuclear receptors. Like PCDDs and PCDFs, 
coplanar PCBs are aryl hydrocarbon receptor 
(AhR) agonists, and PCB-126 accounts for 
52% of the toxic equivalency of dioxin-like 
PCBs in human tissues (NTP 2006b; Safe 
1993). In comparison, some non–dioxin-like 
PCBs such as PCB-153 do not activate AhR 
but may be constitutive androstane receptor 
agonists (Dean et al. 2002). Animal stud-
ies demonstrate that non–dioxin-like PCBs 
such as PCB-153 are concentrated most heav-
ily within the adipose tissue because of their 
high lipid solubility (NTP 2006b). Coplanar 
PCBs, such as PCB 126, despite high lipid 
solubility, paradoxically concentrate primarily 
within the liver (NTP 2006b). In our study, 
both types of PCBs, including PCB-126 and 
PCB-153, were dose-dependently associated 
with ALT elevation.
Extensive animal studies conducted by the 
NTP and others have defined a role for PCBs 
in liver disease. The NTP has performed 2-year 
toxicity studies on PCB-126 and PCB-153 
in female Harlan Sprague-Dawley rats (NTP 
2006a, 2006b, 2006c). These studies dem-
onstrated that the liver was the principal tar-
get organ for these compounds. Both benign 
(toxic hepatopathy, including steatosis) and 
malignant (hepatocellular carcinoma and cho-
langiocarcinoma) liver lesions were observed 
at high frequencies in a dose-dependent 
fashion, particularly in animals treated with 
PCB-126 alone or combined with PCB-153. 
Importantly, both of these PCBs were associ-
ated with human ALT elevation in our study. 
Hennig et al. (2005) demonstrated that PCB-
77 exacerbated high-fat-diet (corn oil)–induced 
hepatic steatosis in mice and increased hepatic 
gene expression of genes involved in apoptosis, 
Table 3. Adjusted ORsa (95% CIs) for ALT elevation by exposure quartile for lead, cadmium, and mercury in adults, NHANES 2003–2004.
Pollutant
Detection rate 
(%)
Not detectable 
(cases/total)
Detectable [median concentration, cases/total, OR (95% CI)] p-Value
First quartile Second quartile Third quartile Fourth quartile Trend Adjusted trendb
Lead (µg/dL) 99.6  
0/6
0.80 
55/579 
Referent
1.30 
48/494 
1.2 (0.9–1.7)
1.90 
53/498 
1.5 (1.0–2.1)
3.30 
49/474 
1.6 (1.1–2.3)
0.006 0.014
Mercury, total (µg/L) 92.5  
12/158 
Referent
0.40 
40/500 
1.1 (0.7–1.8)
0.80 
64/540 
2.0 (1.3–3.2)
1.40 
50/395 
2.2 (1.4–3.5)
3.10 
39/458 
1.6 (1.1–2.4)
0.010 0.014
Cadmium (µg/L) 82.8  
38/345 
Referent
0.30 
73/672 
1.1 (0.7–1.7)
0.40 
21/257 
0.9 (0.6–1.4)
0.60 
38/406 
1.2 (0.8–1.7)
1.10 
35/371 
1.2 (0.7–2.0)
0.503 0.503
aORs were adjusted for age, sex, race, PIR, HOMA-IR, and BMI. bAdditionally adjusted for multiple comparisons.
Table 4. Adjusted ORsa (95% CIs) for ALT elevation by exposure quartile for coplanar PCBs in adults, NHANES 2003–2004.
Pollutant 
(lipid adjusted)
Detection rate 
(%)
Not detectable 
(cases/total)
Detectable [median concentration, cases/total, OR (95% CI)] p-Value
First quartile Second quartile Third quartile Fourth quartile Trend Adjusted trendb
PCB-28 (ng/g) 100.0 2.75 
17/140 
Referent
4.28 
12/151 
0.5 (0.2–1.4)
5.75 
14/141 
0.8 (0.4–1.6)
8.77 
18/139 
1.0 (0.4–2.3)
0.740 0.839
PCB-66 (ng/g) 98.9  
0/8
0.74 
12/135 
Referent
1.18 
8/150 
0.6 (0.2–1.5)
1.67 
25/154 
2.9 (1.6–5.4)
3.00 
18/134 
1.9 (0.9–4.0)
0.003 0.011
PCB-74 (ng/g) 100.0 1.76 
14/142 
Referent
3.32 
15/150 
2.2 (1.0–5.1)
6.82 
19/157 
3.0 (1.5–6.0)
17.88 
15/132 
6.0 (2.4–14.9)
< 0.001 0.004
PCB-105 (ng/g) 98.0  
0/11
0.52 
13/142 
Referent
0.93 
12/150 
1.2 (0.5–3.0)
1.51 
21/144 
2.8 (1.2–6.5)
4.46 
17/131 
3.4 (1.1–10.9)
0.015 0.031
PCB-118 (ng/g) 100.0 2.30 
12/142 
Referent
4.26 
14/158 
1.8 (0.7–4.8)
8.16 
22/144 
3.8 (1.3–11.1)
22.80 
15/135 
4.4 (1.4–13.7)
0.006 0.016
PCB-126 (pg/g) 94.8  
0/33
8.70 
9/134 
Referent
13.80 
12/127 
1.5 (0.6–3.5)
22.00 
22/146 
3.3 (1.5–7.2)
50.50 
18/123 
4.3 (2.0–9.4)
< 0.001 < 0.001
PCB-156 (ng/g) 91.7  
4/49 
Referent
0.90 
15/130 
1.8 (0.6–5.5)
2.74 
14/131 
3.4 (1.3–8.7)
6.11 
16/139 
5.0 (1.5–17.2)
12.40 
14/130 
9.4 (2.5–36.2)
< 0.001 0.004
PCB-157 (ng/g) 74.9  
15/152 
Referent
0.41 
11/111 
1.5 (0.8–2.8)
1.00 
17/105 
4.1 (1.8–9.2)
1.79 
8/100 
2.1 (0.6–7.6)
3.30 
11/105 
7.1 (2.2–22.4)
0.006 0.016
PCB-167 (ng/g) 68.0  
19/188 
Referent
0.50 
9/103 
0.9 (0.4–2.2)
1.10 
12/104 
2.2 (1.0–4.8)
1.93 
11/90 
2.7 (1.0–7.0)
3.81 
11/90 
5.0 (1.9–13.3)
0.003 0.011
PCB-169 (pg/g) 70.3  
14/164 
Referent
7.50 
15/107 
2.4 (0.9–7.0)
13.50 
11/94 
3.5 (1.3–9.7)
22.40 
17/111 
5.0 (1.8–14.0)
39.65 
4/89 
2.4 (0.4–12.8)
0.032 0.061
Coplanar PCBs were measured in serum and are reported as lipid-adjusted values. 
aORs were adjusted for age, sex, race, PIR, HOMA-IR, and BMI. bAdditionally adjusted for multiple comparisons. Cave et al.
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inflammation, and oxidative stress. However, 
this particular coplanar PCB was not measured 
in NHANES 2003–2004. In contrast to ani-
mal studies, human data on PCBs in liver dis-
ease are lacking. However, in Taiwan, 13 years 
after the “Yucheng” incident where cooking 
oil was contaminated by PCBs, the mortality 
rate due to cirrhosis was 2.7 times higher than 
expected (Yu et al. 1997).
Whole-blood total mercury, present 
in 92.5% of subjects, but not urinary total 
(  inorganic plus elemental) mercury, was dose-
  dependently associated with ALT elevation 
and suspected NAFLD. These results suggest 
that the organic form of mercury was associ-
ated with liver disease. MeHg is the principal 
form of organic mercury historically associated 
with organ toxicity. Since the 1950s outbreak 
of Minamata disease (MeHg intoxication) in 
a Japanese fishing village, MeHg has been rec-
ognized as one of the most hazardous environ-
mental pollutants. Coal-fired power plants have 
been identified as the primary source of current 
mercury emissions, and atmospheric mercury 
may be converted into MeHg in water-body 
sediment and subsequently enter the aquatic 
food chain and bioaccumulate in fish (Charnley 
2006). The primary route of human MeHg 
exposure is consumption of contaminated fish 
and shellfish, and PCB coexposure may occur 
(Charnley 2006). MeHg has well-characterized 
toxic effects on the human nervous system, 
developing fetus, and kidney (Charnley 2006).
Despite the fact that MeHg concen-
trates considerably within the liver because of 
enterohepatic recirculation, few animal stud-
ies have examined the potential role of MeHg 
in liver disease. However, acute and chronic 
toxicity studies conducted in rats and cats 
demonstrated that mercury exposure resulted 
in the depletion of body fat, the development 
of centrilobular hepatic steatosis, an increase 
in lipid peroxidation products, the prolifera-
tion of the endoplasmic reticulum, and floc-
cular degeneration of the mitochondria with 
extrusion of diseased organelles into the sinu-
soidal space (Chang and Yamaguchi 1974; 
Desnoyers and Chang 1975a, 1975b; Klein 
et al. 1972; Lin et al. 1996). Many of these 
changes were irreversible after exposure to 
MeHg was discontinued. The primary mecha-
nism of MeHg hepatotoxicity may be related 
to its high affinity for sulfhydryl residues and 
consequent poisoning of cysteine-contain-
ing proteins and glutathione depletion (Lin 
et al. 1996). Previous human epidemiological 
studies have inconsistently linked mercury 
contamination in Japanese fishing villages to 
increased liver-related mortality in villagers 
(Futatsuka et al. 1987, 1992, 2005).
With a detection rate of 99.6%, lead expo-
sure was nearly universal in adult NHANES 
subjects. In contrast to PCBs and MeHg, 
lead hepatotoxicity is relatively well recog-
nized and was recently reviewed (Mudipalli 
2007). Lead exposure most commonly occurs 
through the respiratory or gastrointestinal 
system. Regardless of the route of exposure, 
the liver is the largest lead repository in the 
body (Mudipalli 2007). The pathologic liver 
lesion of lead exposure has been termed “lead-
induced hepatic hyperplasia,” but hepatic 
steatosis has not been reported. Multiple 
molecular events have been described in asso-
ciation with lead-induced hepatic hyperplasia. 
Table 5. Adjusted ORsa (95% CIs) for ALT elevation by exposure quartile for non–dioxin-like PCBs in adults, NHANES 2003–2004.
Pollutant (lipid adjusted)
Detection rate 
(%)
Not detectable 
(cases/total)
Detectable [median concentration, cases/total, OR (95% CI)] p-Value
First quartile Second quartile Third quartile Fourth quartile Trend Adjusted trendb
PCB-44 (ng/g) 99.9 1.00 
17/146 
Referent
1.70 
9/133 
0.6 (0.2–2.1)
2.49 
21/162 
1.2 (0.7–2.0)
4.00 
16/136 
1.0 (0.4–2.7)
0.587 0.734
PCB-49 (ng/g) 99.4  
1/3 
Referent
0.63 
17/146 
0.2 (0.0–3.2)
1.10 
10/131 
0.1 (0.0–2.1)
1.60 
17/155 
0.2 (0.0–2.4)
2.55 
18/139 
0.2 (0.0–4.0)
0.779 0.928
PCB-52 (ng/g) 100.0 1.27 
18/150 
Referent
2.17 
11/128 
0.7 (0.3–1.8)
3.40 
11/159 
0.5 (0.2–1.0)
5.40 
23/143 
1.5 (0.6–3.8)
0.571 0.734
PCB-87 (ng/g) 83.5  
11/95 
Referent
0.57 
16/120 
0.9 (0.5–1.7)
0.90 
5/118 
0.3 (0.1–0.7)
1.20 
13/119 
0.9 (0.5–1.7)
2.01 
18/128 
1.3 (0.6–2.7)
0.354 0.520
PCB-99 (ng/g) 100.0 1.73 
16/139 
Referent
3.15 
13/156 
1.1 (0.5–2.6)
5.40 
19/146 
2.1 (0.6–7.9)
12.90 
15/135 
2.4 (0.7–8.9)
0.149 0.286
PCB-101 (ng/g) 96.6  
2/18 
Referent
0.76 
14/148 
0.3 (0.1–1.8)
1.42 
12/127 
0.3 (0.1–1.5)
2.20 
12/144 
0.4 (0.1–2.1)
4.00 
23/144 
0.7 (0.1–3.9)
0.210 0.336
PCB-110 (ng/g) 98.4  
1/7 
Referent
0.51 
17/152 
0.5 (0.1–5.4)
1.00 
12/138 
0.4 (0.0–4.4)
1.59 
12/146 
0.4 (0.0–4.4)
3.03 
21/136 
0.8 (0.1–6.9)
0.427 0.593
PCB-138 and PCB-158 
(ng/g)
100.0 4.58 
15/148 
Referent
11.07 
14/140 
1.9 (0.8–4.1)
25.10 
15/159 
2.5 (1.0–6.0)
57.98 
19/133 
6.7 (2.1–21.5)
0.001 0.009
PCB-146 (ng/g) 99.2  
0/7
0.61 
14/140 
Referent
1.70 
18/148 
2.2 (1.0–4.5)
4.00 
14/147 
2.7 (1.1–6.9)
8.90 
17/139 
6.8 (1.8–25.5)
0.004 0.019
PCB-149 (ng/g) 95.8  
4/19 
Referent
0.31 
13/135 
0.2 (0.1–0.7)
0.52 
12/133 
0.3 (0.1–0.9)
0.79 
11/160 
0.2 (0.0–0.8)
1.33 
21/129 
0.6 (0.2–2.0)
0.215 0.336
PCB-151 (ng/g) 80.2  
11/115 
Referent
0.19 
14/113 
1.1 (0.3–3.6)
0.30 
8/112 
0.8 (0.3–2.1)
0.41 
10/116 
1.0 (0.4–2.3)
0.79 
19/121 
2.6 (1.2–5.8)
0.030 0.068
PCB-153 (ng/g) 100.0 5.59 
17/145 
Referent
15.18 
13/147 
1.5 (0.6–3.6)
35.01 
14/153 
2.3 (0.7–7.4)
75.55 
19/136 
7.2 (1.7–29.9)
0.006 0.023
PCB-170 (ng/g) 99.2  
0/3
1.40 
15/147 
Referent
4.56 
18/141 
2.1 (1.0–4.3)
11.00 
17/151 
3.1 (1.1–8.7)
22.70 
13/137 
4.4 (1.3–14.4)
0.015 0.042
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Oxidative stress, proinflammatory cytokine 
production and sensitivity, and liver and 
serum cholesterol levels were all increased 
by lead (Aykin-Burns et al. 2003; Honchel 
et al. 1991; Kojima et al. 2004; Milosevic and 
Maier 2000; Sandhir and Gill 1995).
Several potential problems are inherent 
to the design of this study. The exact speci-
ficity of ALT for liver disease in NHANES 
is unknown because liver biopsies were not 
performed. However, ALT should be rela-
tively specific, because the incidence of myo-
pathy, the most important extrahepatic source 
of ALT, is likely low in the general population 
(Green and Flamm 2002). In contrast, at the 
reference range used in this study, the sensitiv-
ity of ALT is likely lower than its specificity. 
In fact, some authors have suggested using 
lower laboratory cutoffs to gain more sensi-
tivity (Prati et al. 2002; Ruhl and Everhart 
2009). Importantly, ALT may be normal in 
NAFLD, and this appears to be an even bigger 
problem in fatty liver and TASH due to some 
industrial chemicals (Brautbar and Williams 
2002; Cave et al. 2010). Therefore, low-level 
environmental pollution may pose an even 
greater risk for liver disease in the general U.S. 
population than suggested by the results of this 
study. Lastly, the cross-sectional study design 
of NHANES cannot determine the direction 
of causation for the identified associations 
between environmental pollutant levels and 
elevated ALT. It is possible that these pollut-
ant concentrations may be elevated because of 
the presence of liver disease or another predis-
posing factor for elevated ALT, rather than the 
risk of elevated ALT being increased because 
of elevated pollutant levels.
The pollutant subclassifications created by 
NHANES, although generally reasonable, may 
not always have the most biologic relevance. 
For example, heavy metals were grouped dif-
ferently according to the method of meas-
urement (blood or urine). Given the large 
number of measured pollutants, looking at all 
possible groupings of pollutants and mixtures 
of subgroups was not practical. However, we 
created new PCB subclasses for coplanar and 
total PCBs because these molecules were con-
sistently associated with ALT elevation.
Regarding PCBs, NHANES reported lev-
els for only a quarter of the 130 manufactured 
PCB congeners, so it must be acknowledged 
that this study did not actually model the 
effects of total lipid-adjusted serum PCB bur-
den. However, because PCBs were sold in 
mixtures, it is likely that subjects high in the 
measured PCBs would also be high in the 
others. As with all other subclasses, members 
of the tetrachlorodibenzo-p-dioxin, PCDDs 
and coplanar PCB subclasses were ranked by 
serum concentration, which did not account 
for their toxic equivalency factors. This 
method allowed us to combine the copla-
nar PCB and non–dioxin-like PCB subclasses 
to form the total PCB subclass. However, 
AhR-dependent hepatotoxicities could be 
examined by alternate models. Also, although 
ranking individuals on the basis of exposure 
levels rather than modeling serum pollutant 
levels directly allowed us to compare results 
between individual pollutants and pollutant 
subclasses, this approach limits comparisons 
with other study populations.
Conclusion
PCBs, lead, and mercury are present in nearly 
all U.S. adults. These common pollutants are 
associated with significant dose-dependent 
increased ORs for ALT elevation in subjects 
whose ALT elevations were not explained by 
Table 5. continued
Pollutant (lipid adjusted)
Detection rate 
(%)
Not detectable 
(cases/total)
Detectable [median concentration, cases/total, OR (95% CI)] p-Value
First quartile Second quartile Third quartile Fourth quartile Trend Adjusted trendb
PCB-172 (ng/g) 77.1  
13/131 
Referent
0.42 
15/120 
1.4 (0.7–3.1)
1.10 
12/107 
2.1 (0.8–5.4)
1.99 
13/119 
2.7 (0.9–8.1)
3.73 
10/100 
3.4 (1.2–9.7)
0.007 0.023
PCB-177 (ng/g) 89.3  
7/60 
Referent
0.53 
9/123 
0.7 (0.4–1.3)
1.30 
16/144 
2.0 (1.0–3.9)
2.70 
15/124 
4.2 (1.7–10.4)
6.00 
16/128 
6.5 (2.8–15.3)
< 0.001 < 0.001
PCB-178 (ng/g) 85.9  
7/70 
Referent
0.40 
16/130 
1.7 (0.8–3.9)
1.20 
13/133 
2.1 (1.0–4.6)
2.44 
17/127 
4.6 (1.4–15.3)
4.86 
10/118 
4.8 (1.3–17.4)
0.014 0.042
PCB-180 (ng/g) 99.8 3.40 
16/145 
Referent
11.90 
17/147 
1.5 (0.7–3.2)
29.40 
19/151 
2.5 (0.9–7.3)
66.51 
11/137 
2.4 (0.6–10.4)
0.206 0.336
PCB-183 (ng/g) 93.6  
2/33 
Referent
0.60 
16/131 
2.4 (0.4–15.4)
1.40 
17/150 
4.0 (0.6–26.8)
2.99 
11/133 
3.1 (0.4–23.2)
6.37 
17/132 
7.8 (0.9–63.9)
0.017 0.042
PCB-187 (ng/g) 99.2  
0/4
1.10 
13/136 
Referent
3.40 
19/158 
2.8 (1.6–5.0)
8.33 
14/142 
4.6 (1.6–13.3)
18.40 
17/138 
10.5 (3.2–34.6)
 < 0.001 0.002
PCB-194 (ng/g) 87.8  
9/68 
Referent
1.00 
17/125 
1.2 (0.6–2.5)
3.57 
13/123 
1.0 (0.4–2.4)
7.87 
15/137 
1.1 (0.4–2.7)
16.57 
9/114 
1.2 (0.3–4.6)
0.881 0.958
PCB-195 (ng/g) 65.5  
26/198 
Referent
0.60 
9/97 
0.6 (0.2–1.6)
1.40 
13/93 
1.3 (0.5–3.4)
2.33 
6/79 
0.6 (0.2–1.8)
4.23 
9/93 
1.2 (0.5–2.9)
0.862 0.958
PCB-196 and PCB-203 
(ng/g)
93.6  
2/38 
Referent
0.80 
18/133 
3.6 (0.9–13.8)
2.60 
13/139 
4.1 (1.1–16.0)
5.92 
16/138 
8.2 (1.7–39.3)
12.50 
14/130 
14.7 (3.3–65.3)
 < 0.001 0.002
PCB-199 (ng/g) 92.8  
4/40 
Referent
0.81 
19/127 
1.9 (0.9–4.2)
3.00 
12/149 
1.2 (0.7–2.1)
7.34 
17/129 
2.5 (1.2–5.3)
16.79 
11/128 
3.3 (0.9–12.4)
0.093 0.194
PCB-206 (ng/g) 96.9  
2/15 
Referent
0.50 
20/148 
1.0 (0.4–2.6)
1.60 
13/141 
0.8 (0.3–2.3)
4.40 
20/140 
1.3 (0.6–3.2)
10.90 
8/131 
0.9 (0.3–2.2)
0.971 0.982
PCB-209 (ng/g) 96.4  
0/18
0.40 
23/147 
Referent
0.93 
15/142 
0.9 (0.4–2.0)
2.73 
14/134 
0.8 (0.4–1.8)
8.79 
10/131 
1.1 (0.3–3.9)
0.982 0.982
Non–dioxin-like PCBs were measured in serum and are reported as lipid-adjusted values. 
aORs were adjusted for age, sex, race/ethnicity, PIR, HOMA-IR, and BMI. bAdditionally adjusted for multiple comparisons. Cave et al.
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viral hepatitis, hemochromatosis, or alcohol 
abuse. These results suggest a possible associa-
tion between low-level environmental pollu-
tion and the development of liver disease and 
suspected NAFLD. Future studies should be 
performed to confirm the potential role of 
these environmental pollutants in NAFLD.
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